NantHealth Inc reports results for the quarter ended in March - Earnings Summary

Nanthealth

06/05/2022 21:55

* NantHealth Inc  NH.OQ  reported a quarterly adjusted loss
of 11
cents​​ per share for the quarter ended in March. The mean
expectation of two analysts for the quarter was for a loss of 9
cents per share.
    * Revenue rose 1.3% to $16.37 million from a year ago; 
analysts
expected $16.43 million. 
    * NantHealth Inc's reported EPS for the quarter was a loss
of 14
cents​.
    * The mean earnings estimate of analysts had fallen by
about 12.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * NantHealth Inc shares had fallen by 7.1% this quarter and
lost 33.6% so far this year.
    * The company reported a quarterly loss of $15.95 million.
    * Wall Street's median 12-month price target for NantHealth
Inc is
$3.25 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated May 6 at 08:54 p.m.  ​All
figures in US dollars unless otherwise stated